Baxter International Inc. (BAX) - Product Pipeline Analysis, 2016 Update

Date: April 6, 2016
Pages: 62
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: BF7B2643CE4EN
Leaflet:

Download PDF Leaflet

Baxter International Inc. (BAX) - Product Pipeline Analysis, 2016 Update
Summary

Baxter International Inc. (Baxter) is one of the leading providers of renal and hospital products. It undertakes the development, manufacture and marketing of medical products, which assist healthcare professionals and their patients in the treatment of end-stage renal diseases. Its portfolio include a comprehensive range of home, acute and in-center dialysis solutions, sterile IV solutions, infusion systems, parenteral nutrition, biosurgery products and anesthetics, and pharmacy automation, software and services. The products find application in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers and clinics. Baxter manufactures its products in over 25 countries and sells them in more than 120 countries. It has wide spread operations in the Americas, Middle East, Africa, Europe and Asia Pacific. Baxter is headquartered in Deerfield, Illinois, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Baxter International Inc.
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Baxter International Inc. Company Snapshot
Baxter International Inc. Company Overview
Baxter International Inc. Pipeline Products and Clinical Trials Overview
Baxter International Inc. – Pipeline Analysis Overview
Business Description
Key Facts
Baxter International Inc. - Major Products and Services
Baxter International Inc. Pipeline Products by Development Stage
Baxter International Inc. Clinical Trials by Trial Status
Baxter International Inc. Pipeline Products Overview
Artis Dialysis System
Artis Dialysis System Product Overview

BAXJECT III

BAXJECT III Product Overview
DurADAPT Bioimplant
DurADAPT Bioimplant Product Overview
Hemopatch
Hemopatch Product Overview
Hemopatch Clinical Trial

INDUCTIGRAFT

INDUCTIGRAFT Product Overview
Infusion Pump
Infusion Pump Product Overview
Next Gen ICHD Monitor
Next Gen ICHD Monitor Product Overview
Non PVC CAPD
Non PVC CAPD Product Overview
Non-DEHP Sets
Non-DEHP Sets Product Overview
Ovart 3D Biodegradable Matrix
Ovart 3D Biodegradable Matrix Product Overview
Prismaflex Integrated With Gas Exchange Technology
Prismaflex Integrated With Gas Exchange Technology Product Overview
Prismaflex Integrated With Gas Exchange Technology Clinical Trial
PrismaLung
PrismaLung Product Overview
PrismaLung Clinical Trial
PrisMAX
PrisMAX Product Overview
ProMaxx Microsphere
ProMaxx Microsphere Product Overview
Synthetic Bone Graft - Orthopaedic
Synthetic Bone Graft - Orthopaedic Product Overview
Synthetic Bone Graft - Spinal
Synthetic Bone Graft - Spinal Product Overview
Theralite
Theralite Product Overview
Theranova 400 Dialyzer
Theranova 400 Dialyzer Product Overview
Tisseel Dura
Tisseel Dura Product Overview

URINFO 3000

URINFO 3000 Product Overview
Veritas-Cardiac Application
Veritas-Cardiac Application Product Overview
VIVIA Hemodialysis System
VIVIA Hemodialysis System Product Overview
VIVIA Hemodialysis System Clinical Trial
Baxter International Inc. - Key Competitors
Baxter International Inc. - Key Employees
Baxter International Inc. - Key Employee Biographies
Baxter International Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Baxter International Inc., Recent Developments
Mar 24, 2016: Baxter Completes CE Mark for Expanded Indication of HEMOPATCH, an Innovative Surgical Patch, In European Union
Mar 15, 2016: Baxter Enrolls First Patient in U.S. Clinical Trial for VIVIA Investigational Home Hemodialysis System
Feb 02, 2016: Baxter Announces Fourth Quarter Results and Provides 2016 Financial Outlook
Jan 26, 2016: Baxter initiates Voluntary Nationwide Recall of Select Lots of IV Solutions Due to the Potential for Leaking Containers and Particulate Matter
Nov 12, 2015: Baxter Completes Capacity Expansion at Halle, Germany Facility to Support BioPharma Solutions’ Oncology Contract Manufacturing Services
Oct 28, 2015: Baxter Names José Almeida Chairman and CEO
Oct 27, 2015: Baxter To Reduce Workforce
Oct 27, 2015: Baxter Reports Strong Third Quarter Financial Results Exceeding Previously Issued Guidance
Oct 21, 2015: Baxter Appoints Michael F. Mahoney to Its Board
Oct 15, 2015: Baxter International expanding operations in Mountain Home
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Baxter International Inc. Pipeline Products and Clinical Trials Overview
Baxter International Inc. Pipeline Products by Equipment Type
Baxter International Inc. Pipeline Products by Indication
Baxter International Inc. Clinical Trials by Trial Status
Baxter International Inc., Key Facts
Baxter International Inc., Major Products and Services
Baxter International Inc. Number of Pipeline Products by Development Stage
Baxter International Inc. Pipeline Products Summary by Development Stage
Baxter International Inc. Clinical Trials by Trial Status
Baxter International Inc. Clinical Trials Summary
Artis Dialysis System - Product Status
Artis Dialysis System - Product Description
BAXJECT III - Product Status
BAXJECT III - Product Description
DurADAPT Bioimplant - Product Status
DurADAPT Bioimplant - Product Description
Hemopatch - Product Status
Hemopatch - Product Description
Hemopatch - A Phase II Prospective, Single Blinded, Randomized Trial of Hemopatch Compared to Standard Techniques to Achieve Air Leak Control After Complex Thoracic Surgical Procedures on High Risk Population for Prolonged Air Leak (more than 5 Days - PAL)
Hemopatch - A Prospective Randomized Trial of Hemopatch Versus No Hemopatch for the Intraoperative Hemostasis During Deceased Donor Renal Transplant
Hemopatch - Prospective Randomized Clinical Trial to Prevent Air Leaks After Lung Resection with Hemopatch Sealing Hemostat: SEALLS (Sealing Evaluation of Air Leaks After Lung Surgery) Trial
Hemopatch - Prospective, Multicenter, Open-label, Randomized, Phase III Clinical Trial of Prevention of Prolonged Air Leak after Lung Resection in High-risk Patients, Applying HEMOPATCH
INDUCTIGRAFT - Product Status
INDUCTIGRAFT - Product Description
Infusion Pump - Product Status
Infusion Pump - Product Description
Next Gen ICHD Monitor - Product Status
Next Gen ICHD Monitor - Product Description
Non PVC CAPD - Product Status
Non PVC CAPD - Product Description
Non-DEHP Sets - Product Status
Non-DEHP Sets - Product Description
Ovart 3D Biodegradable Matrix - Product Status
Ovart 3D Biodegradable Matrix - Product Description
Prismaflex Integrated With Gas Exchange Technology - Product Status
Prismaflex Integrated With Gas Exchange Technology - Product Description
Prismaflex Integrated With Gas Exchange Technology - Effects of AN69 ST Hemofilter on Coagulation During Continuous Renal Replacement Therapy in Critically Ill
PrismaLung - Product Status
PrismaLung - Product Description
PrismaLung - Extracorporeal CO2 Removal (ECCO2R) with a Renal Replacement Platform (PRISMALUNG) to Enhance Lung Protective Ventilation in Patients with Mild to Moderate Acute Respiratory Distress Syndrome (ARDS)
PrismaLung - Low Flow CO2 Removal Via a Membrane Gas Exchange Device (Prismalung) on a Renal Replacement Platform (Prismaflex) in Hypercapnic, Ventilated Patients Requiring Renal Replacement
PrisMAX - Product Status
PrisMAX - Product Description
ProMaxx Microsphere - Product Status
ProMaxx Microsphere - Product Description
Synthetic Bone Graft - Orthopaedic - Product Status
Synthetic Bone Graft - Orthopaedic - Product Description
Synthetic Bone Graft - Spinal - Product Status
Synthetic Bone Graft - Spinal - Product Description
Theralite - Product Status
Theralite - Product Description
Theranova 400 Dialyzer - Product Status
Theranova 400 Dialyzer - Product Description
Tisseel Dura - Product Status
Tisseel Dura - Product Description
URINFO 3000 - Product Status
URINFO 3000 - Product Description
Veritas-Cardiac Application - Product Status
Veritas-Cardiac Application - Product Description
VIVIA Hemodialysis System - Product Status
VIVIA Hemodialysis System - Product Description
VIVIA Hemodialysis System - A Study of Sleep Patterns in Patients Performing Nocturnal Home Dialysis Utilising the VIVIA System
VIVIA Hemodialysis System - U.S. Clinical Trial for VIVIA Investigational Home Hemodialysis System
Baxter International Inc., Key Employees
Baxter International Inc., Key Employee Biographies
Baxter International Inc., Other Locations
Baxter International Inc., Subsidiaries

LIST OF FIGURES

Baxter International Inc. Pipeline Products by Equipment Type
Baxter International Inc. Pipeline Products by Development Stage
Baxter International Inc. Clinical Trials by Trial Status
Skip to top


Ask Your Question

Baxter International Inc. (BAX) - Product Pipeline Analysis, 2016 Update
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: